In my opinion, global large-cap pharmacueticial stocks, including Pfizer , Novartis , Astrazenca , GlaxoSmithKline , Wyeth and Eli Lilly are currently substantially undervalued. These companies are currently paying out huge dividends and trading at sensible P/Es. Unlike their small-cap high-risk research counterparts, these blue-chip stocks represent strong, yet low risk growth. Why risk your money on an obscure new cure for bird-flu, from a dodgy one-man company, when you don't have to?
While sales of their products may be slowing in the OECD developed world, ...
Well this story is a few days old now but it appears for a minute last week we had 1 stock fund in America that did not lose money. One. Now that's a bear market. By the time the article was written on Nov 9th, it was back down to zero. But in a world where -10% means you outperform most of your peers and even the "best and brightest" in hedge fund world, -5% would be fine too. As of yesterday's close Forester Value (FVALX) was only down 3% year to date - so hopefully my blog entry (ok ok, maybe the CBSMarketwatch article) drives some business his way - he only has $40M in assets after...
Goldman upgraded Bed Bath & Beyond (NASDAQ: BBBY) to Buy from Neutral based on valuation and a potential margin rebound at Linens N' Things.
Citigroup upgraded Rockwell Automation Inc. (NYSE: ROK) to Hold from Sell on valuation and believes expectations have been reset to a reasonable level. The company's target was lowered to $27 from $33.
Friedman Billings upgraded shares of Ceradyne (NASDAQ: CRDN) to Outperform from Market Perform on valuation following the recent weakness and t
UPGRADES:Jefferies & Co upgrades Abercrombie & Fitch (NYSE: ANF) from Underperform to Hold.J.P. Morgan upgrades tw telecom (Nasdaq: TWTC) from Underweight to Neutral.Piper Jaffray & Co. upgrades Career Education Corp. (Nasdaq: CECO) from Sell to Neutral. For daily real-time Upgrades go to http://www.streetinsider.com/UpgradesDOWNGRADES:Merrill Lynch downgrades Toyota Motor (NYSE: TM) from Buy to Underperform.Soleil Securities downgrades Dolby Laboratories (NYSE: DLB) from Buy to Hold. Price target $35.UBS downgrades Siemens (NYSE: SI) from Buy to Sell.For daily real-time Downgrades go to ...
Global stock markets are still in the selling pressure and volatility index VIX is already second week above 40 points. In fact this week index is oscillating around level of 50. This is right time for value investor for bargain searching. Many worthy stocks are below P/E 10 with still perspective growth and book value equaling to stock price.
Uncertainty about future attracts more attention to defensive sectors like health-care or consumer staples. I run fundamental stock screen for large cap health-care stocks with P/E below 15 and Price-Book Value below 4. Here is the list of potential va...
Data powered by QuoteMedia.
All Rights Reserved.
Data delayed 15 to 20 minutes unless otherwise indicated.
Terms of Use.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.